Trial
NCT02565901
Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
National Cancer Institute (NCI)
Condition
Castration-Resistant Prostate Carcinoma
Intervention
Carboplatin
Why stopped
Terminated due to insufficient funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-01